Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy-Reference-Cited by-同舟云学术

Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy

Published:2010 Issue:4 Volume:85 Page:386-395
ISSN:0042-1138
Container-title:Urologia Internationalis
language:en
Short-container-title:Urol Int

Author:

Marschner Norbert,Rüttinger Dominik,Zugmaier Gerhard,Nemere Gyula,Lehmann Jan,Obrist Peter,Baeuerle Patrick A.,Wolf Andreas,Schmidt Margit,Abrahamsson Per-Anders,Reinhardt Carsten,Heidenreich Axel

Publisher

S. Karger AG

Subject

Urology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways;International Journal of Molecular Sciences;2024-04-07

2. Visualization of epithelial cell adhesion molecule‑expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with ^99mTc and ¹²⁵I;Oncology Letters;2022-11-17

3. Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside;Experimental Hematology & Oncology;2022-11-11

4. An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages;International Journal of Biological Macromolecules;2022-05

5. Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells;Oncology Reports;2022-03-18